Full-Time

Manager – Global Regulatory Affairs Labeling

Confirmed live in the last 24 hours

Telix Pharmaceuticals

Telix Pharmaceuticals

201-500 employees

Develops targeted radiation therapies for cancer

Biotechnology
Healthcare

Mid, Senior

Remote in USA

Category
Risk & Compliance
Legal & Compliance
Requirements
  • BA/BS in scientific degree (chemistry, biology, pharmaceutical sciences) required. Advanced degree a plus.
  • 5+ years’ experience in regulatory affairs labeling for pharmaceuticals products required
  • Direct experience in writing Target Product Profiles, Target Labeling, Company Core Data Sheets, and local labeling such as USPIs and/or EU SmPCs
  • Experience across product lifecycle (i.e., development to post-marketing)
  • Comprehensive knowledge of the drug development process
  • Ability to understand and interpret Federal, State and Local regulations and guidance documents as well as common and scientific and technical journals.
Responsibilities
  • Independently (with little supervision) lead the development, revision, review, and approval of Target Product Profiles, Target Labeling, Company Core Data Sheets, and Local Labeling.
  • Draft labeling content that is consistent with the company strategy for the product. Collaborate with internal and external colleagues to provide input into labeling documents.
  • Resolve any labeling issues and coordinate approval by the Labeling Management Team.
  • Ensure labeling documents are well-supported by other regulatory documentation (e.g., CSRs, Summary of Clinical Efficacy, Summary of Clinical Safety, etc.) in preparation for submission to Health Authorities.
  • Make recommendations and provide advice and guidance on regulatory documentation to ensure the documents support the labeling.
  • Draft labeling text for packaging components.
  • Collaborate with internal and external colleagues on branding, logos, and design of packaging components.
  • Coordinate artwork creation with manufacturing and supply chain and/or external vendors.
  • Collaborate with Project Management and Global Regulatory Affairs representatives to define timelines for labeling deliverables and ensure those timelines are met.
  • Ensure labeling documents are compliant with internal and external templates, internal standards, and external regulations and guidance.
  • Maintain a high standard of attention to detail with a goal of zero errors in labeling documents meant for a prescriber or patient.
  • Contribute to the continuous improvement of the end-to-end labeling process.
Telix Pharmaceuticals

Telix Pharmaceuticals

View

Telix Pharmaceuticals develops and sells products for diagnosing and treating cancer and rare diseases using targeted radiation. Their products aim to enhance treatment decisions and offer personalized therapy for conditions that lack effective solutions. The company focuses on areas such as prostate and kidney cancers, glioma, sarcoma, and bone marrow conditioning. Telix has a global supply chain to manufacture and distribute its specialized products to healthcare providers and patients. Unlike many competitors, Telix emphasizes sustainability, patient care, and ethical practices in its operations. The goal of Telix Pharmaceuticals is to improve the quality of life for patients by providing advanced diagnostic and therapeutic options.

Company Stage

IPO

Total Funding

$14.8M

Headquarters

Melbourne, Australia

Founded

2015

Growth & Insights
Headcount

6 month growth

19%

1 year growth

41%

2 year growth

105%
Simplify Jobs

Simplify's Take

What believers are saying

  • Telix's completion of the BLA submission for TLX250-CDx positions it for potential market leadership in kidney cancer imaging.
  • Positive data from the ProstACT SELECT trial for TLX591 indicates promising efficacy in prostate cancer treatment, enhancing the company's therapeutic portfolio.
  • The FDA Fast Track designation for TLX101-CDx for glioma imaging accelerates its path to market, potentially improving outcomes for brain cancer patients.

What critics are saying

  • The recent withdrawal of its IPO due to unfavorable market conditions may impact Telix's financial flexibility and investor confidence.
  • The competitive landscape in biopharmaceuticals, especially in oncology, requires continuous innovation to maintain market position.

What makes Telix Pharmaceuticals unique

  • Telix Pharmaceuticals specializes in targeted radiation therapies, setting it apart from traditional biopharmaceutical companies that may not focus on this innovative approach.
  • The company's robust global supply chain ensures the availability and delivery of its products worldwide, providing a competitive edge in distribution and accessibility.
  • Telix's commitment to sustainability and ethical practices integrates patient care and environmental responsibility into its operations, distinguishing it from competitors.

Help us improve and share your feedback! Did you find this helpful?